Today: 22 May 2026
IBM stock holds steady after company confirms death of turnaround CEO Lou Gerstner
29 December 2025
1 min read

IBM stock holds steady after company confirms death of turnaround CEO Lou Gerstner

NEW YORK, December 29, 2025, 11:51 ET — Regular session

  • IBM shares were little changed in late morning trade, bucking a softer broader market.
  • The company said former CEO Lou Gerstner has died at 83, prompting tributes from current CEO Arvind Krishna.
  • Investors are watching thin year-end trading and the run-up to IBM’s next earnings update in late January.

International Business Machines Corp shares were little changed on Monday, trading up 0.02% at $305.15 in late morning, after the company confirmed the death of former chief executive Lou Gerstner.

The news lands in the final week of 2025, when trading can turn choppy as volumes thin and investors rebalance portfolios before the calendar turns.

For IBM shareholders, the next hard test sits a month away: the company’s fourth-quarter earnings update, scheduled for Jan. 28, according to its investor events calendar.

IBM said Gerstner, who led the company from 1993 to 2002, died over the weekend, and CEO Arvind Krishna shared the news with employees in an internal email.

“Lou arrived at IBM at a moment when the company’s future was genuinely uncertain,” Krishna wrote. IBM Newsroom

Gerstner, a former RJR Nabisco CEO and American Express executive, was widely credited with steering IBM away from a breakup and toward services, and the stock finished his tenure far higher than when he started, according to Reuters.

IBM’s muted move came as Wall Street slipped, led by weakness in big technology stocks, with investors looking ahead to Federal Reserve minutes later this week for clues on the 2026 rate path.

The holiday-shortened week is expected to keep volumes light, with U.S. markets closed on Thursday for New Year’s Day, leaving just a few sessions to wrap up 2025.

IBM opened at $304.65 and traded between $303.63 and $306.31 on Monday, data showed.

The backdrop matters for IBM because year-end flows can overwhelm company-specific headlines in the short run, especially in a Dow component that many investors hold through index funds.

When IBM reports next month, investors will focus on whether the company can sustain demand across its software and consulting businesses and how management frames 2026 priorities, including its hybrid cloud strategy — a mix of on-premise systems and public cloud services.

For now, IBM’s stock remained near unchanged as traders weighed the weekend news and a broader market pullback in thin holiday trading.

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
New York, May 22, 2026, 09:08 EDT Akari Therapeutics shares were indicated sharply higher before the Nasdaq open on Friday, after the oncology biotech said its lead cancer drug candidate showed positive preclinical activity in KRAS-mutated pancreatic cancer models and priced a $5.5 million private placement. The stock closed Thursday at $5.14, up 49.85%, and was quoted at $10.15 in premarket trading at 8:39 a.m. EDT, according to StockAnalysis. The move matters because Akari is still a preclinical company, not a revenue-producing drugmaker. Its latest data give investors a fresh reason to look at AKTX-101, while the financing gives the
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Microsoft stock dips as Wall Street’s year-end rally pauses, Fed minutes loom
Previous Story

Microsoft stock dips as Wall Street’s year-end rally pauses, Fed minutes loom

New expressway makes Ahmedabad-to-Salangpur Hanuman temple trip faster — even before official opening
Next Story

New expressway makes Ahmedabad-to-Salangpur Hanuman temple trip faster — even before official opening

Go toTop